Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme targets, enhancing drug efficacy. Commonly employed in research settings for creating analogs with improved metabolic stability and bioavailability. Also utilized in the preparation of radiolabeled compounds for positron emission tomography (PET) imaging studies due to its favorable reactivity and functional group compatibility.